Stakeholder involvement will be crucial for the process of first developing and then implementing a strategic research agenda (SRA). A first stakeholder advisory board (SHAB) meeting was held at the Romanian Office for Science and Technology in Brussels on April 18 with representatives from Action on Antibiotic Resistance (ReACT), European Federation of Pharmaceutical Industries Associations (EFPIA), Federation of European Microbiological Societies (FEMS), Federation of Veterinarians of Europe (FVE), Standing Committee of European Doctors, and WHO Europe. The primary discussion topic was the recent SRA draft. Members of the SHAB will also participate in the upcoming JPIAMR invitational conference in Geneva.
